BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20349694)

  • 21. Care of the pacemaker/implantable cardioverter defibrillator patient in the ED.
    McMullan J; Valento M; Attari M; Venkat A
    Am J Emerg Med; 2007 Sep; 25(7):812-22. PubMed ID: 17870488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "Just Because We Can Doesn't Mean We Should": views of nurses on deactivation of pacemakers and implantable cardioverter-defibrillators.
    Kramer DB; Ottenberg AL; Gerhardson S; Mueller LA; Kaufman SR; Koenig BA; Mueller PS
    J Interv Card Electrophysiol; 2011 Dec; 32(3):243-52. PubMed ID: 21805140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implications of pacemakers and implantable cardioverter defibrillators in urological practice.
    Ubee SS; Kasi VS; Bello D; Manikandan R
    J Urol; 2011 Oct; 186(4):1198-205. PubMed ID: 21849189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deactivation of implantable cardioverter defibrillators in terminal illness and end of life care.
    Kirkpatrick JN; Gottlieb M; Sehgal P; Patel R; Verdino RJ
    Am J Cardiol; 2012 Jan; 109(1):91-4. PubMed ID: 21943937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rights of the terminally ill patient.
    Hodgson J
    Ann Health Law; 1996; (5):169-91. PubMed ID: 10164517
    [No Abstract]   [Full Text] [Related]  

  • 26. The Israeli terminally ill patient law of 2005.
    Jotkowitz AB; Glick S
    J Palliat Care; 2009; 25(4):284-8. PubMed ID: 20131585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urgent implantable cardioverter defibrillator deactivation by unconventional means.
    Beets MT; Forringer E
    J Pain Symptom Manage; 2011 Dec; 42(6):941-5. PubMed ID: 21703815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pacemakers and implantable cardioverter defibrillators--general and anesthetic considerations.
    Rapsang AG; Bhattacharyya P
    Braz J Anesthesiol; 2014; 64(3):205-14. PubMed ID: 24907883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pacemaker and implantable cardioverter-defibrillator use in a US myotonic dystrophy type 1 population.
    Bhakta D; Shen C; Kron J; Epstein AE; Pascuzzi RM; Groh WJ
    J Cardiovasc Electrophysiol; 2011 Dec; 22(12):1369-75. PubMed ID: 22035077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does it make clinical sense to equate terminally ill patients who require life-sustaining interventions with those who do not?
    Alpers A; Lo B
    JAMA; 1997 Jun; 277(21):1705-8. PubMed ID: 9169898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deactivating implantable cardioverter defibrillators.
    Ross HM
    Ann Intern Med; 2005 Nov; 143(9):690; author reply 691. PubMed ID: 16263895
    [No Abstract]   [Full Text] [Related]  

  • 32. I'm getting turned off: emerging consensus on deactivating cardiac implantable electronic devices.
    Kapp MB
    Med Law; 2014 Apr; 33(1):14-21. PubMed ID: 24946510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Voluntary euthanasia: a proposed remedy.
    Cole SS; Shea MS
    Albany Law Rev; 1975; 39(4):826-56. PubMed ID: 11661204
    [No Abstract]   [Full Text] [Related]  

  • 34. Indications for pacemakers, implantable cardioverter-defibrillator and cardiac resynchronization devices.
    Samii SM
    Med Clin North Am; 2015 Jul; 99(4):795-804. PubMed ID: 26042883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ethics of pacemaker deactivation in terminally ill patients.
    Bevins MB
    J Pain Symptom Manage; 2011 Jun; 41(6):1106-10. PubMed ID: 21621131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pacemaker and ICD generator malfunctions: analysis of Food and Drug Administration annual reports.
    Maisel WH; Moynahan M; Zuckerman BD; Gross TP; Tovar OH; Tillman DB; Schultz DB
    JAMA; 2006 Apr; 295(16):1901-6. PubMed ID: 16639048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discussing deactivation of implantable cardiac defibrillators.
    Bahl R; Dubrey S
    Br J Hosp Med (Lond); 2020 Aug; 81(8):1-5. PubMed ID: 32845751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pacemaker and defibrillator deactivation in competent hospice patients: an ethical consideration.
    Ballentine JM
    Am J Hosp Palliat Care; 2005; 22(1):14-9. PubMed ID: 15736602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deactivation of implanted cardioverter-defibrillators at the end of life: results of the EHRA survey.
    Marinskis G; van Erven L;
    Europace; 2010 Aug; 12(8):1176-7. PubMed ID: 20663788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Legal issues of physician-assisted euthanasia. Part III--Passive euthanasia, comparison of international legislation, conclusions for medical practice].
    Laux J; Röbel A; Parzeller M
    Arch Kriminol; 2013; 231(3-4):73-115. PubMed ID: 23678624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.